Filing Flows › Bio Key International (BKYI) › Q1 2026 › vs Q4 2025
Bio Key International (BKYI) Q1 2026 vs Q4 2025 (quarter over quarter)
Bio Key International's revenue rose $1.1M (+98%) from $1.1M in Q4 2025 to $2.1M in Q1 2026. The biggest changes: License +$765K (+127%); Hardware +$357K (+206%); Service −$61K (-20%).
Bio Key International, Q1 2026: revenue $2.1M (+34% year over year), operating margin -7.4%, net loss $205K, operating cash flow −$358K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| License | $1.4M | $601K | $765K | +127% |
| Hardware | $531K | $174K | $357K | +206% |
| Service | $248K | $309K | −$61K | -20% |
| Revenue | $2.1M | $1.1M | $1.1M | +98% |
| Net loss | $205K | $4.3M | −$4.1M | -95% |
| Costs & expenses | $2.4M | $5.4M | −$3.0M | -56% |
| Operating costs | $2.3M | $5.3M | −$3.0M | -56% |
| Interest & other, net | $47K | $62K | −$14K | -23% |
| Cost of revenue | $376K | $271K | $105K | +39% |
| Research & development | $617K | $694K | −$78K | -11% |
| SG&A | $1.3M | $1.8M | −$519K | -28% |
| Operating cash sources | $470K | $2.0M | −$1.5M | -76% |
| Depreciation & amortization | $71K | $76K | −$5K | -6% |
| Share-based compensation | $41K | $61K | −$20K | -33% |
| Cash used in operations | $358K | $1.8M | −$1.5M | -80% |
| Net loss absorbed | $205K | $4.3M | −$4.1M | -95% |
| Working capital & other | $264K | −$2.3M | $2.6M | — |
Questions
How much did Bio Key International's revenue grow quarter over quarter in Q1 2026?
Bio Key International's revenue rose $1.1M (+98%) from $1.1M in Q4 2025 to $2.1M in Q1 2026.
What drove Bio Key International's revenue change in Q1 2026?
License +$765K (+127%); Hardware +$357K (+206%); Service −$61K (-20%).